The Australian Government is investing an additional $6.7 million to support and improve outcomes for all Australians af...
Australian healthtech firm, KISA Pty Ltd, has chosen to set up its global headquarters in the UK and launch its line of ...
The Victorian Government’s $50 million investment in mRNA vaccine manufacturing is welcome recognition of the worl...
Terumo Blood and Cell Technologies and CSL Plasma announced a collaboration to deliver a new plasma collection platform ...
iMDsoft Ltd. and Dedalus on April 20, 201 announced their Channel Partner Agreement, authorizing Dedalus to distribute M...
International medical imaging IT and cybersecurity company Sectra has deployed its software for digital pathol...
The unveiling of a new tool at the Melbourne Centre for Nanofabrication (MCN) to support ground-breaking cancer research...
Rheumatoid arthritis (RA) treatment landscape in Australia is well established with several novel disease-modifying anti...
BC Platforms, a global leader in healthcare data management, analytics and access announced that it has formed a new dat...
The Therapeutic Goods Administration (TGA), part of the Department of Health in Australia, has granted a provisiona...
The Vaccine Safety Investigation Group (VSIG), a panel of expert advisors to the Therapeutic Goods Administration (TGA) ...
The Therapeutic Goods Administration (TGA) in Australia has recently approved wider storage and transportation condition...
An Australian research team conducted the world-first precision-based medicine therapy to cure brain lymphoma at th...
Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical t...
Hygiene and health company Essity, based in Sweden, is acquiring the distribution rights to the wound care technology So...
Fujitsu Australia has acquired Melbourne's digital innovation consulting services company Versor Proprietary Limite...
The largest review of paracetamol for pain relief, led by University of Sydney, Australia, has found only four condition...
Sydney-based Kazia Therapeutics Limited, an oncology-focused drug development company announced that it has entered into...
